Profound Medical
Updated: December 22, 2025
CEO - Arun Menawat
Country: Canada | Funding: $326.2M (+)
Founded: 2008
Website: https://profoundmedical.com/
Profound Medical manufactures a device for MRI-guided transurethral ultrasound ablation of the prostate cancer. TULSA-PRO is an FDA/CE-cleared surgical robot for ablation in men with localized prostate cancer, associated with obstructive benign prostatic hyperplasia (BPH), localized recurrent prostate cancer after radiation therapy or large-volume BPH. The system enables preoperative surgical planning, 360-degree guidance, precise and accurate targeting, automatic energy adjustment and real-time temperature monitoring.
Founded: 2008
Website: https://profoundmedical.com/
Profound Medical manufactures a device for MRI-guided transurethral ultrasound ablation of the prostate cancer. TULSA-PRO is an FDA/CE-cleared surgical robot for ablation in men with localized prostate cancer, associated with obstructive benign prostatic hyperplasia (BPH), localized recurrent prostate cancer after radiation therapy or large-volume BPH. The system enables preoperative surgical planning, 360-degree guidance, precise and accurate targeting, automatic energy adjustment and real-time temperature monitoring.
